Debate Continues on When Best to Use Mesothelioma Chemotherapy

This study is pretty reassuring that half the patients aren’t getting a more optimal or superior approach,” Simone said. “Both are good, accepted approaches. It’s more what the institution is comfortable with, and how the doctors are trained to do it.” European Trial May Be More Definitive The ongoing clinical trial is being done at centers in Belgium, France and the Netherlands. The European Organization for Research and Treatment of Cancer is sponsoring the study. The goal is 64 patients, half of whom will undergo pleurectomy and decortication surgery followed by three cycles of pemetrexed and cisplatin chemotherapy. A second group will receive the same chemotherapy combination before the P/D procedure. “The primary objective of the study is to investigate the feasibility of immediate P/D, followed by chemotherapy, or deferred P/D after chemotherapy in patients with early stage malignant pleural mesothelioma,” the clinical trial authors wrote. The trial started in 2016, hoping to determine if one method is better than the other. Researchers plan to use the more advantageous procedure in a comparative study with either the extrapleural pneumonectomy surgery or a no-surgery control arm. The post Debate Continues on When Best to Use Mesothelioma Chemotherapy appeared first on Mesothelioma Center - Vital Services for Cancer Patients & Families.
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news